AACE Algorithm Guides Individualized Therapy for Type 2 Diabetes Mellitus
September - 7 - 2010
The American Association of Clinical Endocrinologists (AACE) recently revised its treatment algorithm for patients with type 2 diabetes to offer clarification about the many treatment options for these patients. This revision will help patients with diabetes management maintain long-term health and well-being while reducing complications and health risks. The first of these principles is to avoid hypoglycemia, writes Dr. Alan Garber, professor of Medicine at Baylor College of Medicine and treasurer for the AACE. Second in the algorithm is to avoid weight gain, which often accompanies traditional anti-diabetes treatments. The association also advocates multiple therapies begun at the outset, matching the right drugs to the patient profile to provide a more personalized disease management. Garber points out that the new algorithm also emphasizes the use of new incretin therapies, which have minimal risks of hypoglycemia and are either weight-neutral or have the potential for weight loss.
(c)Copyright 2010 Information, Inc.
The information contained in the article above does not necessarily reflect the views and opinions of the American Diabetes Association.
Medscape (08/30/10) Garber, Alan J.